Michael Mason, SVP, CFO & Treasurer at Karyopharm Therapeutics Inc. (KPTI), sold 2,858 shares at $15.52 ($44K) on 2021-02-11, disclosed to the SEC on 2021-02-17.
Open-market sale of $44k KPTI by SVP, CFO & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |